adenylyl imidodiphosphate has been researched along with suramin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escobedo, JA; Keating, MT; Williams, LT | 1 |
| Wieraszko, A | 1 |
| Cipolla-Neto, J; Ferreira, ZS; Markus, RP | 1 |
| Nikbakht, MR; Stone, TW | 1 |
| Almeida, T; Cunha, RA; Oliveira, CR; Richardson, PJ; Rodrigues, RJ | 1 |
| Hohenegger, M; Karel, A; Kassack, MU; Ullmann, H; Wolner, I | 1 |
| De Lorenzo, S; Losavio, A; Muchnik, S; Veggetti, M | 1 |
7 other study(ies) available for adenylyl imidodiphosphate and suramin
| Article | Year |
|---|---|
Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Topics: Adenylyl Imidodiphosphate; Animals; DNA Replication; Mice; Mice, Inbred BALB C; Phosphorylation; Platelet-Derived Growth Factor; Protein Conformation; Receptors, Cell Surface; Receptors, Platelet-Derived Growth Factor; Suramin; Vanadates | 1988 |
Facilitation of hippocampal potentials by suramin.
Topics: 2-Amino-5-phosphonovalerate; Adenylyl Imidodiphosphate; Animals; Dizocilpine Maleate; Evoked Potentials; Hippocampus; In Vitro Techniques; Mice; Mice, Inbred C57BL; Suramin | 1995 |
Presence of P2-purinoceptors in the rat pineal gland.
Topics: Adenosine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Chromatography, High Pressure Liquid; Electrochemistry; Female; In Vitro Techniques; Male; Norepinephrine; Pineal Gland; Rats; Rats, Wistar; Receptors, Purinergic P2; Serotonin; Suramin | 1994 |
Complex hippocampal responses to ATP: fade due to nucleotidase inhibition and P2-receptor-mediated adenosine release.
Topics: 5'-Nucleotidase; Action Potentials; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Enzyme Inhibitors; Hippocampus; Male; Nerve Tissue Proteins; Rats; Rats, Wistar; Receptors, Purinergic P2; Suramin; Theophylline | 2000 |
Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Astrocytoma; Calcium; Cell Line; Cell Line, Tumor; Glutamic Acid; Hippocampus; Kidney; Male; Potassium; Pyramidal Cells; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Presynaptic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Recombinant Fusion Proteins; RNA, Messenger; Subcellular Fractions; Suramin; Synaptosomes; Transfection; Triazines; Triazoles; Xanthines | 2005 |
Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676.
Topics: Adenylyl Imidodiphosphate; Allosteric Regulation; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Calmodulin; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Inhibitory Concentration 50; Ion Channel Gating; Kinetics; Muscle, Skeletal; Myocardium; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Suramin | 2005 |
Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction.
Topics: Acetylcholine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; In Vitro Techniques; Membrane Potentials; Mice; Neural Inhibition; Neuromuscular Junction; Potassium; Presynaptic Terminals; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Suramin; Xanthines | 2006 |